INTRODUCTION
When peripheral blood leukocytes are activated by nonspecific mitogens such as phytohemagglutinin (PHA)l or by antigens to which they have been previously exposed, a potent bone-resorbing factor is secreted into the supernatant medium (2) (3) (4) (5) . We have called this bone-resorbing factor osteoclast activating factor (OAF) and have distinguished it from other humoral mediators of bone resorption such as parathyroid hormone (PTH), active vitamin D metabolites, and prostaglandins by its chemical and biological characteristics (5) . Partial purification of OAF by column chromatography and ultrafiltration yields a macromolecular material which elutes from Sephadex G-100 columns between the molecular weight markers chymotrypsinogen (25,000 daltons) and ribonuclease A (13,700 daltons) (3) . Bone-resorbing factors with similar characteristics are secreted by cultured neoplastic cells derived from patients with myeloma and other hematologic neoplasms associated with hypercalcemia and destructive bone lesions (6) (7) .
In this study we have shown that two distinct peaks of bone-resorbing activity can be found in activated leukocyte culture supernates. The larger peak of activity corresponds to that previously described (3) . The smaller peak can be obtained from the larger under conditions favoring the dissociation of electrostatic bonds and then self-associated back to a larger form in buffers of low ionic strength.
leukocytes. 5 ml of 6% dextran was added to 10-15 ml of the cell-rich plasma which contained 2-5 x 109 leukocytes, of which <5% were neutrophils. The erythrocytes were allowed to sediment by gravity. The buffy coat was separated from the erythrocytes, and the leukocytes were counted in a Neubauer counting chamber. The leukocytes were diluted in fresh BGJ medium (chemically defined medium developed by Biggers et al. [1] ) without added proteins (8) to a concentration of 1-2 x 106 cells/ml. The method of cell culture was essentially similar to that described before (4) , except that the cells were cultured in 1,000-3,000-ml Ehrlenmyer flasks, with 500 ml of culture medium in each flask. The duration of culture was from 18 to 24 h in an atmosphere of 5% CO2 in air at 37°C. The cells were stimulated to produce OAF by 1% PHA-M, (Grand Island Biological Co., Grand Island, N. Y.). At the end of culture, the supernatant media was decanted and filtered to remove the cells before further study. This medium was then stored at -20°C. The supematant media from these cultures contained amounts of bone-resorbing activity per cell comparable to that produced by the leukocytes cultured under the conditions that we have described before (2) (3) (4) (5) .
Bioassay for bone resorption. The bioassay used for assessing bone resorption has been described before in detail (4, 8, 9) . In brief, pregnant rats at the 18th day of gestation were injected with 0. (Fig. 1) . The apparent shoulder in this chromatogram was not regularly observed and is within the limits of error of the assay. The major peak is similar to that reported previously (3) . However, when the filtrate from the PM10 membrane was in turn concentrated on a UM2 membrane (assigned molecular weight cutoff 1,000 daltons) and chromatographed on a Sephadex G-50 column, the bone-resorbing activity eluted in two peaks. One of these peaks coincided with the previously described peak and eluted from the column with chymotrypsinogen and ribonuclease A. This peak is henceforth called big OAF (Fig. 4) . The same material on a Bio-Gel P6 column eluted between the molecular weight markers calcitonin (3,500 daltons) and vitamin B12 (1,330 daltons) (Fig. 5) .
Little OAF self-association. When the biological activity which eluted from Sephadex G-50 columns in the little OAF area was equilibrated by dialysis in buffers of low ionic strength (Tris-HCl 50 mM) and rechromatographed on a Sephadex G-50 column in Tris-HCl buffer, the biological activity eluted from the column in two peaks, corresponding approximately to the previously observed peaks for big and little OAF (Fig. 6 ). When the biological activity which had passed through an Amicon PM10 membrane after equilibration in 1 M NaCl was reequilibrated in Tris-HCl 10 mM, the biological activity was retained by the Amicon membrane (Fig. 7) . These data confirm that under conditions of low ionic strength, little OAF self-associates back to big OAF. Dialysis of little OAF. Little OAF obtained by
Amicon ultrafiltration after dissociation with 1 M NaCl was dialyzed using boiled Spectrapor no. 3 dialysis tubing (assigned molecular weight cutoff 3,500 daltons). All of the biological activity was retained inside the dialysis membrane (Table II) . After dialysis, there was a marked increase in biological Extraction in ethyl acetate. The biological activity, which eluted from Sephadex G-50 columns and BioGel P6 columns in the Little OAF area or which was prepared by salt dissociation and Amicon ultrafiltration, was extracted in ethyl acetate after acidification of the medium to pH 3.5 (Table III) . Under these circumstances, all the biological activity appeared in the organic phase. When the pH of the medium was When the OAF was equilibrated with 1 M NaCl, all of the 3io-Gel P6 gel filtration of little OAF prepared activity passed through the membrane on diafiltration with 10 ion of big OAF with 1 M NaCl as in Fig. 4 . vol of phosphate-buffered saline, ionic strength 150 mM, was equilibrated in phsophate-buffered saline, (center-pair of assays). When this little OAF was equilith 150 mM, pH 7.2. The column markers are brated with Tris-HCl 10 mM, the activity was retained by A (13,700 daltons), calcitonin (3,500 daltons), PM1O membrane after diafiltration with 10 vol of this same B,2 ( 4 As in Fig. 2 . § As in Table I. "Prepared by gel filtration, as in Fig. 1 Assay for prostaglandin-like activity. Purified little OAF after ethyl acetate extraction (Table V) was assayed for prostaglandin-like activity at a concentration which had maximal bone resorbing activity. The concentration of prostaglandin-like activity by the rat-fundus assay found in the sample was less than the equivalent of0.1 nM ofprostaglandins E. Prostaglandin E2 is the most potent known bone-resorbing prostaglandin (11) , but concentrations of 1-10 uM are required to produce maximal bone resorption. Thus, the biological activity in little OAF samples cannot be ascribed to known prostaglandins.
Purification steps. Table V shows a summary of the stepwise purification of OAF achieved by ultrafiltration, salt dissociation, column chromatography, and extraction in ethyl acetate. The final sample was over 6,000-fold purified compared with the original leukocyte supernate and contained a protein concentration of 80 ng/ml as measured by the method of Lowry et al. (12) . DISCUSSION The present study shows that the bone-resorbing activity produced by PHA-activated leukocyte culture supernates which we have termed OAF is heterogeneous. There are two distinct peaks of bone resorbing activity which can be distinguished by gel filtration chromatography. We have called the larger peak big OAF and the smaller peak little OAF. Both of these peaks have similar biological effects to those previously described for OAF (5) . After equilibration of big OAF with 1 M NaCl or 2 M urea, the biological activity can be eluted from Sephadex G-50 columns in the same fraction as little OAF, thus suggesting that little OAF is either a subunit ofbig OAF or is bound to a 25,000 12,500 glandins of biologically active peaks eluting from Sephadex columns did not show sufficient concentrations of PTH or prostaglandins to account for the boneresorbing activity found (3). Like PTH, OAF probably depends on a peptide sequence for biological activity as little OAF was inactivated by proteolytic enzymes (Table IV) . The impure preparations ofbig OAF used in these experiments were not activated by proteolytic enzymes, possibly due to the presence of contaminating proteins in the sample. Using different purification methods, we found big OAF to be inactivated by these enzymes previously (3) .
Although little OAF, but not big OAF, could be extracted into ethyl acetate after acidification, it is unlikely that little OAF is a prostaglandin. Bioassay of active little OAF preparations for prostaglandin-like activity indicated that there was not enough prostaglandin-like activity present to account for the boneresorbing activity. Moreover, the dissociation/selfassociation properties of OAF, the retention of biological activity after dialysis, and the loss of biological activity after incubation with proteolytic enzymes all suggest that the bone-resorbing activity of little OAF preparations is not due to known prostaglandins o: prostaglandin-like compounds.
It is likely that little OAF escaped detection initially because it is not present in crude leukocyte supernates in concentrations as great as big OAF, and because it has a steep biphasic dose-response curve with significant inhibition of activity at concentrations only two-to fourfold greater than those giving maximal activity. Thus, unless multiple dilutions are bioassayed, bone-resorbing activity may be missed in samples which contain potent biological activity. The reason for decreased activity of little OAF prep- arations at high concentrations is uncertain. The inhibitory effect can be removed by dialysis (Table II) . It is possible that little OAF preparations contain a natural inhibitor or that the hypertonic solutions obtained after salt dissociation are responsible for the inhibition of bone resorption. Little OAF has been difficult to purify further because the biological activity is not retained after more than a few weeks at -20°C. Nevertheless, the methods used have resulted in a high degree of purification, with over a 6,000-fold increase in specific activity of the most purified sample relative to the original starting material.
The relationship of OAF to other lymphokines is unknown at present. Human macrophage migration inhibition factor and chemotactic factor are probably larger than OAF and elute from Sephadex G-100 columns around the chymotrypsinogen marker (25,000 daltons) (13) . Current evidence suggests that human lymphotoxin is also considerably larger than OAF (14) . OAF is not the only lymphokine which shows more than one peak of biological activity on Sephadex chromatography. There is some evidence that chemotactic factor is heterogeneous and may undergo reaggregation (14) . We have not assayed OAF preparations for chemotactic activity, but the reported behavior of chemotactic factor on Sephadex columns does not correspond with that of OAF.
It is possible that OAF is an important mediator of bone resorption both in health and disease. We have found that cultured neoplastic cells in patients with myeloma and a number of other B-cell lymphoproliferative disorders produce a bone-resorbing factor with similar chemical and biological characteristics to OAF (6, 7) . Positive identification of these factors and their differentiation from OAF awaits more specific assays and further purification. OAF could be produced either by the neoplastic cells or by normal leukocytes in the cellular immune response stimulated by tumors. OAF is also a potential mediator of the bone resorption which occurs adjacent to areas ofchronic inflammatory cell infiltration in diseases such as rheumatoid arthritis, periodontal disease and cholesteatoma (15) . Krane et al. (16) have found that cultured synovial cells from patients with rheumatoid arthritis secrete a bone resorbing factor smaller than big OAF but distinct from prostaglandins which are also produced by synovial cell cultures (17) .
